Renaissance Technologies
IMUX icon

Renaissance Technologies’s Immunic IMUX Stock Holding History

Renaissance Technologies’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.02M Buy
+91,916
New +$823K ﹤0.01% 2270
2025
Q4 		– Sell
-39,165
Closed -$345K – 3480
2025
Q3 		$345K Buy
39,165
+25,950
+196% +$229K ﹤0.01% 2945
2025
Q2 		$92.2K Sell
13,215
-53,731
-80% -$493K ﹤0.01% 3312
2025
Q1 		$730K Buy
66,946
+10,284
+18% +$111K ﹤0.01% 2579
2024
Q4 		$567K Buy
56,662
+17,754
+46% +$224K ﹤0.01% 2784
2024
Q3 		$642K Buy
38,908
+9,799
+34% +$140K ﹤0.01% 2668
2024
Q2 		$323K Sell
29,109
-45,618
-61% -$567K ﹤0.01% 2882
2024
Q1 		$986K Buy
74,727
+67,246
+899% +$874K ﹤0.01% 2495
2023
Q4 		$112K Sell
7,481
-50,259
-87% -$616K ﹤0.01% 3276
2023
Q3 		$849K Buy
57,740
+42,250
+273% +$812K ﹤0.01% 2413
2023
Q2 		$389K Sell
15,490
-22,256
-59% -$373K ﹤0.01% 3002
2023
Q1 		$562K Buy
+37,746
New +$701K ﹤0.01% 2820
2022
Q4 		– Sell
-13,067
Closed -$413K – 4248
2022
Q3 		$413K Buy
13,067
+10,147
+348% +$425K ﹤0.01% 3042
2022
Q2 		$101K Buy
+2,920
New +$187K ﹤0.01% 3850
2021
Q4 		– Sell
-1,670
Closed -$148K – 4057
2021
Q3 		$148K Buy
+1,670
New +$164K ﹤0.01% 3262
2021
Q1 		– Sell
-1,340
Closed -$205K – 3491
2020
Q4 		$205K Sell
1,340
-2,200
-62% -$395K ﹤0.01% 3130
2020
Q3 		$657K Sell
3,540
-12,453
-78% -$2.04M ﹤0.01% 2718
2020
Q2 		$1.94M Buy
15,993
+9,200
+135% +$936K ﹤0.01% 2201
2020
Q1 		$411K Buy
6,793
+730
+12% +$58.7K ﹤0.01% 2853
2019
Q4 		$588K Buy
6,063
+1,860
+44% +$155K ﹤0.01% 2839
2019
Q3 		$420K Buy
4,203
+2,830
+206% +$379K ﹤0.01% 2931
2019
Q2 		$157K Buy
1,373
+1,341
+4,191% +$176K ﹤0.01% 3340
2019
Q1 		$3K Buy
+32
New +$2.81K ﹤0.01% 3414
2018
Q2 		– Sell
-57
Closed -$154K – 3399
2018
Q1 		$154K Sell
57
-116
-67% -$266K ﹤0.01% 3217
2017
Q4 		$412K Buy
173
+37
+27% +$81.8K ﹤0.01% 2928
2017
Q3 		$275K Buy
+136
New +$177K ﹤0.01% 2927
2015
Q3 		– Sell
-45
Closed -$377K – 3250
2015
Q2 		$377K Buy
+45
New +$429K ﹤0.01% 2805

Other funds holding IMUX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Renaissance Technologies's IMUX Position: Q1 2026 in Review

Renaissance Technologies opened a new position in Immunic (IMUX) in Q1 2026: 91,916 shares worth $1.02M. The stake represents ﹤0.01% of the portfolio and ranks #2270 among its holdings. This is a return to the name: Renaissance Technologies previously reported a position in IMUX as recently as Q3 2025.

Renaissance Technologies first reported a position in IMUX in Q2 2015 and has held it in 27 quarters since. The position peaked at $1.94M in Q2 2020. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.

  • Renaissance Technologies held 91,916 shares of Immunic worth $1.02M as of Q1 2026.
  • Immunic was a new Renaissance Technologies position in Q1 2026.
  • Immunic made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #2270 holding.
  • Renaissance Technologies first reported a position in Immunic in Q2 2015 and has held it in 27 quarters since.
  • Renaissance Technologies's Immunic position peaked at $1.94M in Q2 2020.
  • 75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.